Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Digestive System Neoplasms × Immune Checkpoint Inhibitors × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Triple Negative Breast Neoplasms 1 Solid Tumor, Adult 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1

Interventions

Gemcitabine 5 Irinotecan 4 130-nm albumin-bound paclitaxel 4 Albumin-Bound Paclitaxel 3 napabucasin 2 Leucovorin 2 Imatinib Mesylate 2 Everolimus 2 Cisplatin 2 Ascorbic Acid 2 spartalizumab 1 pralsetinib 1 pembrolizumab 1 dostarlimab 1 copanlisib 1 alectinib 1 Ramucirumab 1 Paclitaxel 1 Levoleucovorin 1 KRN-330 1 HhAntag691 1 Fluorouracil 1 Cyclophosphamide 1 Capecitabine 1 Bevacizumab 1 5,10-methylenetetrahydrofolic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡